ACTIVE

SANOPHAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

98,6 k €

-43.2% YoY

Gross margin

352,7 k €

-13.1% YoY

Equity

477,1 k €

+0.1% YoY

Workforce

2,9 ETP

+7.4% YoY

What does SANOPHAR do?

SANOPHAR is a Public limited company incorporated in 2000. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Menen. It employs on average 2,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0471.640.823

Incorporation

14/04/2000

Legal form

Public limited company

Registered office

Volkslaan 111
8930 Menen · FlandreSee on map

Contributed capital

355 772,67 €

Latest accounts

31/12/2025

Average workforce

2,9 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	352,7 k €	-13.1%	406,1 k €	+10.8%	366,4 k €	-43.4%	647,3 k €	-7.9%	703,1 k €	+5.2%	668,5 k €	+7.3%	622,8 k €	-3.8%	647,2 k €	+4.3%	620,4 k €	+6.8%	581 k €	+1.9%	569,9 k €	+13.4%	502,6 k €	-4.7%	527,1 k €	+9.7%	480,7 k €	+11.8%	429,9 k €	+94.0%	221,6 k €	+84.0%	120,5 k €	+15.5%	104,2 k €
EBITDA	124,3 k €	-37.0%	197,2 k €	+26.9%	155,4 k €	-18.2%	190 k €	-33.1%	284,1 k €	+5.8%	268,5 k €	+7.1%	250,6 k €	-12.0%	284,7 k €	+8.6%	262,1 k €	+20.3%	217,9 k €	-9.0%	239,4 k €	+24.5%	192,4 k €	-20.4%	241,8 k €	+9.2%	221,4 k €	+24.9%	177,2 k €	+535%	27,9 k €	-66.3%	82,9 k €	+21.2%	68,4 k €
Operating result	112,5 k €	-38.7%	183,7 k €	+57.2%	116,8 k €	-28.3%	162,9 k €	-35.1%	250,8 k €	+23.0%	203,9 k €	+22.9%	165,9 k €	-25.0%	221,4 k €	+10.1%	201,1 k €	+32.8%	151,5 k €	-13.9%	176 k €	+44.7%	121,6 k €	-22.8%	157,4 k €	+31.5%	119,8 k €	+33.5%	89,7 k €	+338%	-37,8 k €	-216%	32,4 k €	+52.5%	21,3 k €
Net result	98,6 k €	-43.2%	173,7 k €	+55.0%	112,1 k €	-28.1%	155,9 k €	-24.0%	205,1 k €	+7.0%	191,7 k €	+20.9%	158,5 k €	-7.7%	171,9 k €	-10.2%	191,3 k €	+32.9%	144 k €	-7.8%	156,2 k €	+50.6%	103,7 k €	-26.4%	140,9 k €	+60.1%	88 k €	+22.6%	71,7 k €	+259%	-45,1 k €	-330%	19,6 k €	+86.9%	10,5 k €
Balance sheet
Equity	477,1 k €	+0.1%	476,5 k €	+0.0%	476,2 k €	+0.0%	476,2 k €	+0.2%	475,3 k €	+125%	211,2 k €	+0.8%	209,4 k €	+1.7%	205,9 k €	+53.6%	134,1 k €	+9.2%	122,7 k €	+12.9%	108,7 k €	+6.0%	102,5 k €	+3.8%	98,8 k €	+19.2%	82,9 k €	+16.9%	70,9 k €	+5.6%	67,1 k €	-40.2%	112,2 k €	+21.2%	92,6 k €
Total assets	1,2 M €	-1.4%	1,2 M €	-4.3%	1,2 M €	-7.3%	1,3 M €	+23.2%	1,1 M €	-6.8%	1,2 M €	+1.1%	1,1 M €	+2.0%	1,1 M €	+11.4%	1 M €	+2.9%	982,7 k €	-8.9%	1,1 M €	+4.9%	1 M €	-9.3%	1,1 M €	+2.8%	1,1 M €	+6.8%	1 M €	+33.9%	771,1 k €	+44.5%	533,6 k €	+14.6%	465,5 k €
Cash	256,6 k €	+9.0%	235,5 k €	-37.5%	376,9 k €	+25.3%	300,9 k €	+15.8%	259,8 k €	-16.2%	310 k €	-12.1%	352,6 k €	+13.0%	312,1 k €	+27.2%	245,4 k €	+56.8%	156,5 k €	-41.8%	269 k €	+34.4%	200,2 k €	+1.7%	196,8 k €	+43.6%	137,1 k €	-27.6%	189,4 k €	+154%	74,7 k €	+68.4%	44,4 k €	-25.5%	59,6 k €
Debts	690,3 k €	-2.5%	707,8 k €	-7.1%	761,7 k €	-11.2%	858,1 k €	+42.8%	601 k €	-36.4%	945,7 k €	+0.5%	940,5 k €	+2.1%	921,1 k €	+5.0%	877,3 k €	+2.0%	859,9 k €	-7.6%	930,4 k €	+2.4%	908,5 k €	-9.1%	999,8 k €	+0.1%	998,8 k €	+7.7%	927,8 k €	+43.9%	644,9 k €	+54.1%	418,4 k €	+14.3%	366 k €
Other
Workforce	2,9 ETP	+7.4%	2,7 ETP	-3.6%	2,8 ETP	-54.1%	6,1 ETP	-22.8%	7,9 ETP	+38.6%	5,7 ETP	0.0%	5,7 ETP	+5.6%	5,4 ETP	0.0%	5,4 ETP	-3.6%	5,6 ETP	0.0%	5,6 ETP	0.0%	5,6 ETP	0.0%	5,6 ETP	+7.7%	5,2 ETP	+8.3%	4,8 ETP	+29.7%	3,7 ETP	+270%	1,0 ETP	0.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 27 ended

Active mandates

VEMAPHAR

Director · since 09 juin 2020 · 0471.640.427

Represented by Verbeke Koen

Active

geroFarma

Director · 0774.941.908

Represented by Loosveldt Fien

Active

Ended mandates

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by veronique Maertens

Ended

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by Maertens Veronique

Ended

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by Maertens Veronique

Ended

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by veronique Maertens

Ended

At this address

Other companies at this address

Company	CBE no.
Farmave● Active	0770.922.148
GROEP SANOVE● Active	1006.858.911

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	01/07/2026	07/07/2025	27/08/2024	20/07/2023	15/07/2022	28/06/2021
General meeting	09/06/2026	10/06/2025	11/06/2024	13/06/2023	24/06/2022	08/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	09/06/2026	01/07/2026	Dutch	PDF
Abridged model	31/12/2024	10/06/2025	07/07/2025	Dutch	PDF
Abridged model	31/12/2023	11/06/2024	27/08/2024	Dutch	PDF
Abridged model	31/12/2022	13/06/2023	20/07/2023	Dutch	PDF
Abridged model	31/12/2021	24/06/2022	15/07/2022	Dutch	PDF
Abridged model	31/12/2020	08/06/2021	28/06/2021	Dutch	PDF
Abridged model	31/12/2019	09/06/2020	28/08/2020	Dutch	PDF
Abridged model	31/12/2018	12/06/2019	10/07/2019	Dutch	PDF
Abridged model	31/12/2017	12/06/2018	29/08/2018	Dutch	PDF
Abridged model	31/12/2016	13/06/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	07/07/2016	31/08/2016	Dutch	PDF
Abridged model	31/12/2014	25/06/2015	06/07/2015	Dutch	PDF
Abridged model	31/12/2013	08/07/2014	29/08/2014	Dutch	PDF
Abridged model	31/12/2012	09/07/2013	29/08/2013	Dutch	PDF
Abridged model	31/12/2011	26/06/2012	31/08/2012	Dutch	PDF
Abridged model	31/12/2010	12/07/2011	30/08/2011	Dutch	PDF
Abridged model	31/12/2009	06/07/2010	23/08/2010	Dutch	PDF
Abridged model	31/12/2008	09/07/2009	27/08/2009	Dutch	PDF
Abridged model	31/12/2007	01/08/2008	25/08/2008	Dutch	PDF
Abridged model	31/12/2006	12/06/2007	29/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 27 ended

Active mandates

VEMAPHAR

Director · since 09 juin 2020 · 0471.640.427

Represented by Verbeke Koen

Active

geroFarma

Director · 0774.941.908

Represented by Loosveldt Fien

Active

Ended mandates

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by veronique Maertens

Ended

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by Maertens Veronique

Ended

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by Maertens Veronique

Ended

APOTHEEK MAERTENS

Director · since 09 juillet 2014 · until 09 juin 2020 · 0479.049.643

Represented by veronique Maertens

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office28/09/2023
MAATSCHAPPELIJKE ZETEL
PDF
Mandates17/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares13/08/2021
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Restructuring14/05/2021
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates18/01/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/06/2015
ONTSLAGEN - BENOEMINGEN
PDF
Registered office16/06/2008
BENAMING - MAATSCHAPPELIJKE ZETEL
PDF
Mandates04/02/2008
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202598,6 k €↓
2024
Annual accounts 2024173,7 k €↑
2023
Annual accounts 2023112,1 k €↓
2022
Annual accounts 2022155,9 k €↓
2021
Annual accounts 2021205,1 k €↑
2018
Annual accounts 2018191,7 k €↑
2017
Annual accounts 2017158,5 k €↓
2016
Annual accounts 2016171,9 k €↓
2015
Annual accounts 2015191,3 k €↑
2014
Annual accounts 2014144 k €↓
2013
Annual accounts 2013156,2 k €↑
2012
Annual accounts 2012103,7 k €↓
2011
Annual accounts 2011140,9 k €↑
2010
Annual accounts 201088 k €↑
2009
Annual accounts 200971,7 k €↑
2008
Annual accounts 2008-45,1 k €↓
2007
Annual accounts 200719,6 k €↑
2007
Name changeSANOPHAR
2006
Annual accounts 200610,5 k €
2006
Name changeAPOTHEEK LUDWIG VERBEKE
14/04/2000
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

SANOPHAR

Overview

What does SANOPHAR do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline